Bottom line
RYBOX vs IBB: the short answer
RYBOX (Biotechnology Fund) and IBB (iShares Biotechnology ETF) are both mutual funds.
But IBB is far broader, holding 254 positions to 74 for RYBOX, so beyond the top names it adds exposure RYBOX doesn't have.
IBB is cheaper at 0.44% vs 1.63% — a difference of $119 a year per $10,000 invested.
Over five years, RYBOX returned +2.8% a year vs +2.5% for IBB.
RYBOX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYBOX vs IBB side by side
| RYBOX | IBB | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | iShares |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.63% | 0.44% |
| Annual cost per $10k | $163 | $44 |
| 10-yr cost on $10k (prospectus) | $2,364 | $555 |
| Max front load | 4.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +24.2% | +28.0% |
| 5-yr return (annualized) | +2.8% | +2.5% |
| 10-yr return (annualized) | +5.1% | +4.4% |
| Best quarter | — | +26.8% |
| Worst quarter | — | −22.9% |
| Net assets (fund) | $136.8M | $5.9B |
| Number of holdings | 74 | 254 |
| Portfolio turnover | 75% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of RYBOX's top 25 holdings also appear in IBB's top 25.
| Holding | RYBOX | IBB |
|---|---|---|
| Amgen Inc | 5.05% | 7.50% |
| Gilead Sciences Inc | 4.49% | 7.52% |
| Vertex Pharmaceuticals Inc | 4.32% | 7.66% |
| Regeneron Pharmaceuticals Inc | 2.93% | 5.70% |
| Alnylam Pharmaceuticals Inc | 2.36% | 5.68% |
| Beone Medicines Ltd | 2.17% | 2.11% |
| Moderna Inc | 2.15% | 0.88% |
| Biogen Inc | 2.13% | 2.03% |
| Natera Inc | 2.12% | 2.11% |
| Illumina Inc | 1.94% | 1.41% |
| Insmed Inc | 1.79% | 2.95% |
| United Therapeutics Corp | 1.72% | 1.82% |
| Incyte Corp | 1.62% | 1.62% |
| Neurocrine Biosciences Inc | 1.52% | 1.34% |
| Argenx Se | 1.48% | 3.15% |
Source: SEC Form N-PORT
RYBOX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
IBB top 10
- BlackRock Funds III — 13.18%
- Vertex Pharmaceuticals, Inc. — 7.66%
- Gilead Sciences, Inc. — 7.52%
- Amgen, Inc. — 7.50%
- Regeneron Pharmaceuticals, Inc. — 5.70%
- Alnylam Pharmaceuticals, Inc. — 5.68%
- IQVIA Holdings, Inc. — 3.18%
- Argenx SE — 3.15%
- Insmed, Inc. — 2.95%
- Mettler-Toledo International, Inc. — 2.49%
FAQ
What is the difference between RYBOX and IBB?
Which is cheaper, RYBOX or IBB?
Should I own both RYBOX and IBB?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.